Country Trust Bank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.51K | Buy |
83
+38
| +84% | +$3.18K | ﹤0.01% | 382 |
|
|
2026
Q1 | $3.6K | Hold |
45
| – | – | ﹤0.01% | 423 |
|
|
2025
Q4 | $3.84K | Hold |
45
| – | – | ﹤0.01% | 444 |
|
|
2025
Q3 | $3.5K | Sell |
45
-18
| -29% | -$1.41K | ﹤0.01% | 470 |
|
|
2025
Q2 | $4.93K | Buy |
+63
| New | +$4.7K | ﹤0.01% | 368 |
|
|
2024
Q1 | – | Sell |
-5
| Closed | -$381 | – | 327 |
|
|
2023
Q4 | $381 | Sell |
5
-300
| -98% | -$20.9K | ﹤0.01% | 332 |
|
|
2023
Q3 | $21.1K | Hold |
305
| – | – | ﹤0.01% | 208 |
|
|
2023
Q2 | $28.8K | Hold |
305
| – | – | ﹤0.01% | 195 |
|
|
2023
Q1 | $25.2K | Hold |
305
| – | – | ﹤0.01% | 197 |
|
|
2022
Q4 | $22.8K | Hold |
305
| – | – | ﹤0.01% | 218 |
|
|
2022
Q3 | $25K | Sell |
305
-85
| -22% | -$8.18K | ﹤0.01% | 227 |
|
|
2022
Q2 | $37K | Sell |
390
-190,838
| -100% | -$19.8M | ﹤0.01% | 205 |
|
|
2022
Q1 | $22.5M | Buy |
191,228
+3,065
| +2% | +$344K | 0.63% | 65 |
|
|
2021
Q4 | $24.4M | Sell |
188,163
-53,072
| -22% | -$6.19M | 0.66% | 60 |
|
|
2021
Q3 | $27.3M | Sell |
241,235
-5,988
| -2% | -$683K | 0.8% | 54 |
|
|
2021
Q2 | $25.6M | Sell |
247,223
-3,626
| -1% | -$342K | 0.76% | 57 |
|
|
2021
Q1 | $21M | Sell |
250,849
-49,197
| -16% | -$4.16M | 0.67% | 63 |
|
|
2020
Q4 | $27.4M | Sell |
300,046
-968
| -0.3% | -$80.3K | 0.94% | 43 |
|
|
2020
Q3 | $24M | Sell |
301,014
-18,339
| -6% | -$1.43M | 0.92% | 49 |
|
|
2020
Q2 | $22.1M | Buy |
319,353
+8,790
| +3% | +$625K | 0.89% | 48 |
|
|
2020
Q1 | $19.5M | Sell |
310,563
-12,186
| -4% | -$879K | 0.88% | 50 |
|
|
2019
Q4 | $25.1M | Sell |
322,749
-35,706
| -10% | -$2.79M | 0.99% | 49 |
|
|
2019
Q3 | $26.3M | Sell |
358,455
-226,302
| -39% | -$15.9M | 1.14% | 39 |
|
|
2019
Q2 | $36M | Sell |
584,757
-978
| -0.2% | -$59.1K | 1.57% | 21 |
|
|
2019
Q1 | $37.4M | Buy |
585,735
+31,482
| +6% | +$1.8M | 1.66% | 17 |
|
|
2018
Q4 | $28.3M | Buy |
554,253
+71,382
| +15% | +$3.61M | 1.41% | 22 |
|
|
2018
Q3 | $28M | Sell |
482,871
-34,515
| -7% | -$1.69M | 1.3% | 26 |
|
|
2018
Q2 | $25.1M | Buy |
517,386
+97,956
| +23% | +$4.57M | 1.08% | 40 |
|
|
2018
Q1 | $19.5M | Buy |
419,430
+306,480
| +271% | +$13.3M | 0.93% | 48 |
|
|
2017
Q4 | $4.24M | Buy |
+112,950
| New | +$4.15M | 0.18% | 81 |
|
|
2017
Q1 | – | Sell |
-156
| Closed | -$5K | – | 199 |
|
|
2016
Q4 | $5K | Buy |
+156
| New | +$5.05K | ﹤0.01% | 194 |
|
|
2015
Q4 | – | Sell |
-240
| Closed | -$6K | – | 225 |
|
|
2015
Q3 | $6K | Buy |
+240
| New | +$5.79K | ﹤0.01% | 200 |
|
Other funds holding EW
WT
Country Trust Bank's EW Position: Q2 2026 in Review
Country Trust Bank increased its Edwards Lifesciences (EW) stake by 84% in Q2 2026, buying an estimated $3.18K and bringing the position to 83 shares worth $7.51K. The position accounts for ﹤0.01% of the portfolio, ranked #382.
Country Trust Bank first reported a position in EW in Q3 2015 and has held it in 32 quarters since. The position peaked at $37.4M in Q1 2019. 973 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Country Trust Bank held 83 shares of Edwards Lifesciences worth $7.51K as of Q2 2026.
- Country Trust Bank bought 38 Edwards Lifesciences shares in Q2 2026, an estimated $3.18K.
- Edwards Lifesciences made up ﹤0.01% of Country Trust Bank's portfolio in Q2 2026, its #382 holding.
- Country Trust Bank first reported a position in Edwards Lifesciences in Q3 2015 and has held it in 32 quarters since.
- Country Trust Bank's Edwards Lifesciences position peaked at $37.4M in Q1 2019.
- 973 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Country Trust Bank's 13F filing for Q2 2026, filed 15 Jul 2026.